Jaguar Health Inc. (JAGX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Jaguar Health Inc.

    NASDAQ: JAGX · Real-Time Price · USD
    2.12
    0.07 (3.41%)
    At close: Sep 26, 2025, 1:12 PM

    Jaguar Health Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 11.69M 9.76M 11.96M 4.33M
    Cost of Revenue
    		 1.96M 2.04M 2.02M 2.33M
    Gross Profit
    		 9.73M 7.72M 9.94M 2M
    Operating Income
    		 -30.83M -34.29M -34.41M -39.07M
    Interest Income
    		 n/a n/a n/a 8.42M
    Pretax Income
    		 -39.25M -41.9M -48.4M -52.6M
    Net Income
    		 -38.49M -41.3M -47.45M -60.25M
    Selling & General & Admin
    		 24.02M 23.05M 26.7M 26M
    Research & Development
    		 16.54M 18.6M 17.65M 15.08M
    Other Expenses
    		 n/a 371K n/a n/a
    Operating Expenses
    		 40.56M 42.02M 44.35M 41.08M
    Interest Expense
    		 231K 6.38M 12.72M 8.42M
    Selling & Marketing Expenses
    		 7.69M 6.46M 8.84M 8.89M
    Cost & Expenses
    		 42.52M 44.05M 46.37M 43.41M
    Income Tax Expense
    		 n/a n/a n/a 7.65M
    Shares Outstanding (Basic)
    		 294.53K 15.42K 11.69 5.31
    Shares Outstanding (Diluted)
    		 294.53K 15.42K 11.69 5.31
    EPS (Basic)
    		 -130.69 -2.69K -4.07M -11.37M
    EPS (Diluted)
    		 -130.69 -2.69K -4.07M -11.37M
    EBITDA
    		 -36.66M -33.13M -33.38M -42.35M
    EBIT
    		 -39.02M -33.92M -35.67M -44.18M
    Depreciation & Amortization
    		 2.36M 1.16M 2.29M 1.83M

    Add to Watchlist